or Try an Advanced Search...

    Transplantation Medicine Stocks List

    Symbol Grade Name % Change
    CDNA C CareDx, Inc. 5.86
    HUMA B Humacyte, Inc. 1.47
    MDXG D MiMedx Group, Inc -2.51
    PLUR D Pluri Inc. -3.91
    TMDX A TransMedics Group, Inc. 0.88
    XTNT F Xtant Medical Holdings, Inc. 5.88
    ZIMV D ZimVie Inc. -0.44
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Devices
    Related Stock Lists: Surgery Medicine Allotransplantation Biotechnology Disease Health Sciences Immunology Life Sciences Organ Transplantation Transplantation Acute Respiratory Distress Syndrome Back Pain Biologics Biopharmaceutical Blood Test Boat Bone Bone Fracture Bone Grafting Breakthrough Therapy

    Related ETFs - A few ETFs which own one or more of the above listed Transplantation Medicine stocks.

    Symbol Grade Name Weight
    CBSE A Changebridge Capital Sustainable Equity ETF 5.78
    CBLS A Changebridge Capital Long/Short Equity ETF 4.92
    ARKG D ARK Genomic Revolution Multi-Sector ETF 3.43
    XHE C SPDR S&P Health Care Equipment 3.14
    JFWD D Jacob Funds Inc. Jacob Forward ETF 2.58
    View all Transplantation Medicine ETFs...
    Compare ETFs
    Compare ARKG to JFWD Compare ARKG to XHE Compare CBLS to JFWD

        Transplantation Medicine Stocks Recent News

        Date Stock Title
        May 6 HUMA Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024
        May 6 TMDX TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
        May 5 TMDX TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2024 Earnings Call Transcript
        May 3 CDNA CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
        May 3 TMDX Will TransMedics (TMDX) Gain on Rising Earnings Estimates?
        May 3 TMDX TransMedics Group, Inc. (TMDX) Soars to 52-Week High, Time to Cash Out?
        May 3 TMDX Should You Think About Buying TransMedics Group, Inc. (NASDAQ:TMDX) Now?
        May 3 TMDX TransMedics Group First Quarter 2024 Earnings: Beats Expectations
        May 2 TMDX Is TransMedics (TMDX) a Buy as Wall Street Analysts Look Optimistic?
        May 1 TMDX Why TransMedics Stock Is Soaring Today
        May 1 TMDX Q1 2024 Transmedics Group Inc Earnings Call
        May 1 TMDX TransMedics Group Inc (TMDX) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and ...
        May 1 TMDX TransMedics Group, Inc. (TMDX) Q1 2024 Earnings Call Transcript
        Apr 30 TMDX TransMedics Group Inc (TMDX) Surpasses Analyst Revenue Forecasts with Stellar Q1 2024 Results
        Apr 30 TMDX TransMedics (TMDX) Beats Q1 Earnings and Revenue Estimates
        Apr 30 TMDX TransMedics Group GAAP EPS of $0.35 beats by $0.36, revenue of $96.85M beats by $13.08M
        Apr 30 TMDX TransMedics Reports First Quarter 2024 Financial Results
        Apr 30 XTNT Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds
        Apr 29 TMDX TransMedics Group Q1 2024 Earnings Preview
        Apr 29 CDNA CareDx to Report First Quarter 2024 Financial Results
        Related Industries: Biotechnology Diagnostics & Research Medical Devices
        Related Stock Lists: Surgery Medicine Allotransplantation Biotechnology Disease Health Sciences Immunology Life Sciences Organ Transplantation Transplantation Acute Respiratory Distress Syndrome Back Pain Biologics Biopharmaceutical Blood Test Boat Bone Bone Fracture Bone Grafting Breakthrough Therapy
        Transplantation Medicine

        Transplantation Medicine is a branch of medicine that focuses on the diagnosis, treatment, and prevention of organ transplantation. It involves the use of medical techniques to replace or repair damaged or diseased organs with healthy organs from a donor. Transplantation Medicine also includes the study of the immune system and its response to transplanted organs, as well as the development of new treatments and technologies to improve the success of organ transplants.

        Browse All Tags